Symbols

CLBT

Cellebrite DI·NASDAQ

--(--)

Signals Analysis

Bullish signal 3

Bearish signal 1

Consensus Rating "Strong Buy"

Ample Liquidity

High Gross Profit Margin

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About CLBT

Cellebrite Di Ltd.

AI-driven digital investigation and intelligence software solutions

Industry

Software

Established Date

04/13/1999

Listing Date

11/06/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

1,285

Fiscal Year Ends

12-31

Website

www.cellebrite.com

Security Type

Common stock

Office address

94 Shlomo Shmelzer Road, Petah Tikva, 4970602, Israel

Business

Introduction

Cellebrite DI Ltd., was incorporated under the laws of Israel on April 13, 1999. The company provides artificial intelligence-driven digital investigation and intelligence software solutions that assist law enforcement, defense, intelligence agencies, and businesses in accessing, collecting, and analyzing digital evidence during the investigation cycle. Its technology supports investigations conducted in accordance with the law and enhances mobile research and application security.

Company Financials

EPS

CLBT has released its 2025 Q4 earnings. EPS was reported at 0.14, versus the expected 0.11, beating expectations. The chart below visualizes how CLBT has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

CLBT has released its 2025 Q4 earnings report, with revenue of 128.82M, reflecting a YoY change of 18.13%, and net profit of 21.26M, showing a YoY change of 10.34%. The Sankey diagram below clearly presents CLBT's revenue sources and cost distribution.